Dr. Reddy’s Laboratories launches Treprostinil Injection in U.S. market

Treprostinil Injection, a therapeutically equivalent generic version of Remodulin (treprostinil) Injection, has been introduced by Dr. Reddy’s Laboratories on the American market (USFDA). Treprostinil Injection from the supplier is offered in vials with a 20 mg/20 mL, 50 mg/20 mL, 100 mg/20 mL, or 200 mg/20 mL dose. Hyderabad, Telangana, India is home to the multinational pharmaceutical company Dr. Reddy’s Laboratories. It produces and sells a variety of pharmaceuticals both in India and abroad.

Shopping Cart
Scroll to Top